MedTrace Logo

A Prospective Randomized Study Comparing the Target Volume for Limited-stage Small Cell Lung Cancer

NCT01731548 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 500

Last updated 2013-01-23

No results posted yet for this study

Summary

We hypothesized that the local control for both arms were not statistically significant, when irradiation to the post-induction chemotherapy tumor volume is compared with irradiation to the pre-induction chemotherapy tumor volume.While elective nodal irradiation will be omitted for both arms.

Conditions

  • Carcinoma of Lung
  • Small Cell
  • Limited Stage

Interventions

RADIATION

hyperfractionated radiation therapy for both arms

1.5 Gy twice daily to 45 Gy in 30 fractions over 3 weeks for both arms

Sponsors & Collaborators

  • Sun Yat-sen University

    collaborator OTHER

  • Zhejiang Cancer Hospital

    lead OTHER

Principal Investigators

  • Ming Chen, MD · Zhejiang Cancer Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-06-30
Primary Completion
2014-12-31
Completion
2016-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01731548 on ClinicalTrials.gov